Skip to content

Interest coverage at other companies

Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
-55,882.3×
Arcus Biosciences logo
Arcus BiosciencesRCUS
-39.8×-15.5×
Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
-84.7×
Incyte logo
IncyteINCY
689.3×+620×
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
-5×-1.1×
Gilead Sciences logo
Gilead SciencesGILD
10.3×+2.0×

Other financials

Income statement

See full
Revenue-
Gross profit-
Operating income-$9.3M-52.6%
Net income-$8.4M-44.6%
EPS (diluted)-$0.05+28.6%

Balance sheet

See full
Cash & equivalents$107.1M+277%
Total debt$871.0K+0.1%
Total equity$107.4M+287%
Total assets$114.2M+227%

Cash flow

See full
Operating cash flow-$8.8M+2.5%

Valuation

See full
Market cap$1.8B+674%

Profitability

See full
Gross margin90%-7.4pp
Operating margin-4,195%-4,591pp
Net margin-4,130.1%-4,444pp
FCF margin-300.5%

Returns & leverage

See full
Return on equity-43.6%-17.9pp
Debt / equity0.0×
Current ratio17.2×+12.6×

Where this comes from

Calculated from SELLAS Life Sciences Group, Inc.’s reported figures.

Based on trailing twelve months.

The official record: SELLAS Life Sciences Group, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about SELLAS Life Sciences Group, Inc.'s interest coverage.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is SELLAS Life Sciences Group, Inc.'s interest coverage?
SELLAS Life Sciences Group, Inc. (SLS) reported interest coverage of -15.7× in Q1 2026.
How has SELLAS Life Sciences Group, Inc.'s interest coverage changed year-over-year?
SELLAS Life Sciences Group, Inc.'s interest coverage increased by 54.9% year-over-year, from -34.8× to -15.7×.
What is the long-term trend for SELLAS Life Sciences Group, Inc.'s interest coverage?
Over 2 years (2023 to 2025), SELLAS Life Sciences Group, Inc.'s interest coverage has grown at a -47.3% compound annual growth rate (CAGR), from -72.1× to -20×.
What does interest coverage mean?
Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.